SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. & Encou...
November 04 2016 - 12:46PM
Business Wire
Khang & Khang LLP (the “Firm”) announces a class action
lawsuit against Spectrum Pharmaceuticals, Inc. (“Spectrum” or the
“Company”) (Nasdaq: SPPI). Investors, who purchased or otherwise
acquired shares between February 28, 2013 and September 16, 2016
inclusive (the “Class Period”), are encouraged to contact the Firm
in advance of the November 21, 2016 lead plaintiff motion
deadline.
If you purchased shares of Spectrum during the Class Period,
please contact Joon M. Khang, Esquire, of Khang & Khang, 18101
Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949)
419-3834, or via e-mail at joon@khanglaw.com.
There has been no class certification in this case. Until
certification occurs, you are not represented by an attorney. You
may choose to take no action and remain a passive class member.
The complaint alleges that Spectrum made false and/or misleading
statements and/or failed to disclose that: the FDA previously
questioned whether the data from the 611 and 612 Studies (the names
of the Phase 3 studies for apaziquone) were clinically significant;
that the FDA instructed the Company in December 2012 not to submit
the New Drug Application based on data from the 611 and 612
Studies; and that as a result of the above, the Company’s public
statements regarding its business, operations and prospects were
materially false and misleading at all relevant times. When this
information was disclosed, shares of Spectrum declined in
value.
If you wish to learn more about this lawsuit at no
charge, or if you have questions concerning this notice or your
rights, please contact Joon M. Khang, a prominent litigator for
almost two decades, by telephone: (949) 419-3834, or via e-mail at
joon@khanglaw.com.
This press release may constitute Attorney Advertising in some
jurisdictions.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161104005826/en/
Khang & Khang LLPJoon M. Khang, Esq.Telephone:
949-419-3834Facsimile: 949-225-4474joon@khanglaw.com
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Apr 2023 to Apr 2024